Antibody Drug Conjugates Against the Receptor for Advanced Glycation End Products (RAGE), a Novel Therapeutic Target in Endometrial Cancer

Journal for ImmunoTherapy of Cancer - United Kingdom
doi 10.1186/s40425-019-0765-z

Related search